Page 96 | Certara

On-Demand Webinar

RAPS Sponsored Webcast: Oops, I messed Up! How to Avoid (and Fix) Common Regulatory Submission Mistakes

Oops, I made a mistake! Everyone has made or seen one, and sometimes it is…

CertaraMarch 9, 2023

Press Release

Certara announces the release of Simcyp™ PBPK Simulator Version 22, expanding ability to simulate untested scenarios for new patient and therapeutic types

Simcyp Simulator has been utilized to inform more than 300 label claims for 90+ novel…

CertaraMarch 7, 2023

Fact Sheet

GlobalSubmit™ eCTD Platform

GlobalSubmit enables teams to simplify the eCTD submission process to successfully publish, validate, and review…

CertaraMarch 3, 2023

Blog

Drug Development Considerations for Live Biotherapeutic Products

A new class of complex biologics has emerged in recent years. These are classified in…

CertaraMarch 3, 2023

Conference

ISMPP 2024

CertaraMarch 3, 2023

Case Study

Agent-Based Model Predicts Impact of Monoclonal Antibody Treatment, Prophylaxis & Vaccines on Viral Transmission during Pandemic

Agent-based models focus on the heterogeneous behavior of individual agents and their interactions with one…

CertaraMarch 2, 2023

Press Coverage

Advancing data discovery in the life sciences through artificial intelligence

Vyasa has developed deep-learning artificial intelligence solutions for organizations looking to solve the complex data…

CertaraMarch 2, 2023

Video

Vyasa Demo

CertaraMarch 2, 2023

Press Release

Certara Announces Transition Plan For Chief Financial Officer

PRINCETON, N.J. – March 1, 2023 – Certara, Inc. (Nasdaq: CERT), announced today that John…

CertaraMarch 1, 2023

On-Demand Webinar

Learn how to create CDISC domains in minutes with PK Submit

Creating CDISC domains as part of the pharmacokinetic (PK) deliverable for regulatory submissions can be…

CertaraMarch 1, 2023

RAPS Sponsored Webcast: Oops, I messed Up! How to Avoid (and Fix) Common Regulatory Submission Mistakes

Certara announces the release of Simcyp™ PBPK Simulator Version 22, expanding ability to simulate untested scenarios for new patient and therapeutic types

GlobalSubmit™ eCTD Platform

Drug Development Considerations for Live Biotherapeutic Products

ISMPP 2024

Agent-Based Model Predicts Impact of Monoclonal Antibody Treatment, Prophylaxis & Vaccines on Viral Transmission during Pandemic

Advancing data discovery in the life sciences through artificial intelligence

Vyasa Demo

Certara Announces Transition Plan For Chief Financial Officer

Learn how to create CDISC domains in minutes with PK Submit

Newsletter sign up

Quick links

Solutions

Contact